BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38760750)

  • 1. Drug stewardship in chronic kidney disease to achieve effective and safe medication use.
    Hall RK; Kazancıoğlu R; Thanachayanont T; Wong G; Sabanayagam D; Battistella M; Ahmed SB; Inker LA; Barreto EF; Fu EL; Clase CM; Carrero JJ
    Nat Rev Nephrol; 2024 Jun; 20(6):386-401. PubMed ID: 38491222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy.
    Gupta JK; Ravindrarajah R; Tilston G; Ollier W; Ashcroft DM; Heald AH
    Cardiovasc Endocrinol Metab; 2024 Jun; 13(2):e0304. PubMed ID: 38799205
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.
    Zhang B; Wang J; Liu N; Liu W; Xi R; Wang P
    BMC Nephrol; 2024 May; 25(1):169. PubMed ID: 38760750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and trends of polypharmacy in U.S. adults, 1999-2018.
    Wang X; Liu K; Shirai K; Tang C; Hu Y; Wang Y; Hao Y; Dong JY
    Glob Health Res Policy; 2023 Jul; 8(1):25. PubMed ID: 37434230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018.
    Wang X; Yang C; Jiang J; Hu Y; Hao Y; Dong JY
    Front Public Health; 2023; 11():1116583. PubMed ID: 37033012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of potentially inappropriate medications and association with comorbidities in older adults with diabetes in an outpatient visitation setting.
    Lu L; Yao K; Chen J; Yang Y; Wang K; Zheng J; Guo P; Cai Y; Zhang Q
    Front Public Health; 2022; 10():995948. PubMed ID: 36203703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials.
    Fu H; Hou W; Zhang Y; Hu X
    PLoS One; 2022; 17(5):e0269111. PubMed ID: 35617324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Polypharmacy, Anxiety, and Depression Among Chinese Older Adults: Evidence from the Chinese Longitudinal Healthy Longevity Survey.
    Cheng C; Bai J
    Clin Interv Aging; 2022; 17():235-244. PubMed ID: 35283629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic variation of multimorbidity in Colombian older adults.
    Ballesteros SM; Moreno-Montoya J; Grooten WJA; Barrera-López P; De la Hoz-Valle JA
    Sci Rep; 2021 Nov; 11(1):22738. PubMed ID: 34815507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
    Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
    Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
    J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between number of medications and mortality among older adult patients in a specialized cardiology hospital.
    Arita T; Suzuki S; Yagi N; Otsuka T; Kishi M; Kano H; Matsuno S; Kato Y; Uejima T; Oikawa Y; Matsuhama M; Iida M; Yajima J; Yamashita T
    Geriatr Gerontol Int; 2021 Nov; 21(11):985-995. PubMed ID: 34549500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy is associated with malnutrition and activities of daily living disability among daycare facility users: A cross-sectional study.
    Nakamura T; Itoh T; Yabe A; Imai S; Nakamura Y; Mizokami Y; Okouchi Y; Ikeshita A; Kominato H
    Medicine (Baltimore); 2021 Aug; 100(34):e27073. PubMed ID: 34449506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polypharmacy with falls among older Chinese inpatients: A nationwide cohort study.
    Zhang XM; Jiao J; Guo N; Bo HX; Xu T; Wu XJ
    Geriatr Gerontol Int; 2021 Sep; 21(9):810-817. PubMed ID: 34318576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology, polypharmacy and the older adult: a review.
    Robinson P
    Br J Community Nurs; 2021 Jun; 26(6):290-295. PubMed ID: 34105364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.
    Min HK; Sung SA; Chung W; Kim YH; Chae DW; Ahn C; Oh KH; Park SK; Lee SW
    Kidney Blood Press Res; 2021; 46(4):460-468. PubMed ID: 34091449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the spatial-temporal distribution and evolution of population aging and social-economic indicators in China.
    Man W; Wang S; Yang H
    BMC Public Health; 2021 May; 21(1):966. PubMed ID: 34020620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.
    Pazan F; Wehling M
    Eur Geriatr Med; 2021 Jun; 12(3):443-452. PubMed ID: 33694123
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.